Remove Bioavailability Remove Branding Remove Containment
article thumbnail

Expert Insights: Development and Manufacture of Highly Potent Oral Liquids

XTalks

This additional six months of market exclusivity can translate into significant revenue , offering pharmaceutical companies a lucrative opportunity to capitalize on branded drug sales during this extended period. Best practices include the use of contained engineering solutions to safeguard drug product integrity and protect operators.

article thumbnail

EverGrain’s Line of Barley-Based Products Scores Upcycled Certification

XTalks

After five years of research and development, the brand found a way to transform saved grain from brewing into nutrient-rich, barley-based proteins and fibers that have a variety of applications in the food and beverage industry. EverGrain’s UFA Certification. Related: Will Pecan Milk Find Success in the Crowded Plant-Based Dairy Space?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Compliance to convenience: understanding the latest innovations in capsule formulation

Pharmaceutical Technology

Softgel capsules, containing a liquid, paste or emulsion active ingredient, are trusted and favoured by many patients. They also offer enhanced bioavailability, exact dosing and an extended shelf life. For companies, it creates possibilities for portfolio diversification and brand differentiation. Chewable capsules and gummies.

article thumbnail

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

Furthermore, the bioavailability of the active pharmaceutical ingredient (API) into the cornea is up to four times stronger with EyeSol technology. The solution of Vevye does not contain water, anti-microbial preservatives, oils or surfactants. Vevye (cyclosporine ophthalmic solution) 0.1

article thumbnail

Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development

The Pharma Data

These compounds have demonstrated high potency in inhibiting the activity of the M pro protease as well as promising oral bioavailability and blood plasma levels in animal studies. “Sosei Heptares” is the corporate brand and trademark of Sosei Group Corporation, which is listed on the Tokyo Stock Exchange (ticker: 4565).